These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3239276)

  • 1. [Factors influencing the duration of function of arteriovenous vascular anastomoses in hemodialysis].
    Scholz VH; Naundorf M; Wolff H; Precht K; Röseler E; Schulze BD; Nieter B; Matthes G
    Z Urol Nephrol; 1988 Oct; 81(10):629-33. PubMed ID: 3239276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular changes at the puncture segments of arteriovenous fistula for hemodialysis access.
    Hsiao JF; Chou HH; Hsu LA; Wu LS; Yang CW; Hsu TS; Chang CJ
    J Vasc Surg; 2010 Sep; 52(3):669-73. PubMed ID: 20620004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting hemodialysis access failure with the measurement of dialysis access recirculation.
    Hamidian Jahromi A; Morsy M; Chemla E
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):486-7; author reply 487. PubMed ID: 19414961
    [No Abstract]   [Full Text] [Related]  

  • 4. Survival of vascular access during daily and three times a week hemodialysis.
    Quintaliani G; Buoncristiani U; Fagugli R; Kuluiranu H; Ciao G; Rondini L; Lowenthal DT; Reboldi G
    Clin Nephrol; 2000 May; 53(5):372-7. PubMed ID: 11305810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the survival of permanent vascular access ports].
    Rodríguez JA; Ferrer E; Olmos A; Codina S; Borrellas J; Piera L
    Nefrologia; 2001; 21(3):260-73. PubMed ID: 11471307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive methods to identify early vascular access dysfunction.
    Soule JL; Henry ML
    Semin Vasc Surg; 2007 Sep; 20(3):164-6. PubMed ID: 17884617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The syndrome of retrograde venous arterialization following arteriovenous vascular anastomoses for hemodialysis].
    Scholz H; Naundorf M; Wolff H; Precht K; Röseler E; Schulze BD; Reinke P; Schoepke WD
    Z Urol Nephrol; 1988 Nov; 81(11):675-9. PubMed ID: 3213278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some old drugs improve late primary patency rate of native arteriovenous fistulas in hemodialysis patients.
    Righetti M; Ferrario G; Serbelloni P; Milani S; Tommasi A
    Ann Vasc Surg; 2009; 23(4):491-7. PubMed ID: 18973987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodialysis vascular access monitoring for stenosis.
    Ravenscroft EF; Ganz G
    CANNT J; 1999; 9(2):16-20. PubMed ID: 11778253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine surveillance in vascular access for hemodialysis.
    Henry ML
    Eur J Vasc Endovasc Surg; 2006 Nov; 32(5):545-8. PubMed ID: 16934500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Angiological and neurological problems after shunt surgery in haemodialysis patients].
    Brittinger WD
    Handchir Mikrochir Plast Chir; 2005 Jun; 37(3):167-75. PubMed ID: 15997427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical bypass of symptomatic central venous obstruction for arteriovenous fistula salvage in hemodialysis patients.
    Suliman A; Greenberg JI; Angle N
    Ann Vasc Surg; 2008 Mar; 22(2):203-9. PubMed ID: 18346573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilia and the risk for hemodialysis vascular access thrombosis.
    Knoll GA; Wells PS; Young D; Perkins SL; Pilkey RM; Clinch JJ; Rodger MA
    J Am Soc Nephrol; 2005 Apr; 16(4):1108-14. PubMed ID: 15728780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experience with vascular access in hemodialysis treatment of acute and chronic renal insufficiency].
    Lamarca S; Virzì S
    Chir Ital; 1982 Oct; 34(5):709-26. PubMed ID: 6927092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Subcutaneous vascular access].
    Heinrich P; Müller JS
    Z Urol Nephrol; 1988 Mar; 81(3):167-71. PubMed ID: 3388996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polytetrafluoroethylene graft's complications in patients on hemodialysis.
    Kraev Z; Kirjakov Z; Antonov S; Stantchev I; Zlatarska S
    Przegl Lek; 1985; 42(4):442-3. PubMed ID: 4048538
    [No Abstract]   [Full Text] [Related]  

  • 17. Percutaneous therapy to maintain dialysis access successfully prolongs functional duration after primary failure.
    Bakken AM; Galaria II; Agerstrand C; Saad WE; Surowiec SM; Singh MJ; Rhodes JM; Lee D; Patel NC; Illig KA; Waldman DL; Davies MG
    Ann Vasc Surg; 2007 Jul; 21(4):474-80. PubMed ID: 17499964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous access for patients with chronic kidney disease.
    Saad TF; Vesely TM
    J Vasc Interv Radiol; 2004 Oct; 15(10):1041-5. PubMed ID: 15466788
    [No Abstract]   [Full Text] [Related]  

  • 19. New approach to vascular access revascularisation: the Hydrolyser Thrombectomy Catheter.
    Martinez JF; Momblanch T; Pallares M; Alonso J; Sanz A; Marti A
    EDTNA ERCA J; 1996; 22(4):26-8. PubMed ID: 10723345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of primary failure in native AV-fistulae (early fistula failure).
    Ohira S; Kon T; Imura T
    Hemodial Int; 2006 Apr; 10(2):173-9. PubMed ID: 16623671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.